--- bibliography: 'morinlab.bib' csl: 'NLM.csl' link-citations: true --- [[_TOC_]] ## Overview CD70 is a costimulatory molecule expressed on some activated lymphocytes and has a role in T-cell-mediated immune responses. CD70 aberrations are relatively common in DLBCL and appear more frequent in certain DLBCL patient populations. For instance, in a Chinese DLBCL cohort, 24% of cases exhibited CD70 genetic changes, compared to 10.8% in a Swedish cohort.[@nieDualRoleCD702022] CD70 mutations are associated with the BN2 genetic subtype of DLBCL.[@wrightProbabilisticClassificationTool2020] The mutation pattern in CD70 is consistent with the preferential accumulation of *inactivating mutations*. Genetic perturbation limits the development of an effective CD8+ T-cell immune response in Bcl6-driven DLBCL. [@nieDualRoleCD702022] In mouse models, CD70 loss promoted lymphomagenesis, consistent with its role as a tumor suppressor gene in B-cell lymphomas.[@mandatoAbstractA38Cd702022] ## Relevance tier by entity |Entity|Tier|Description | |:------:|:----:|--------------------------------------| |![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@morinFrequentMutationHistonemodifying2011]| |![FL](images/icons/FL_tier2.png) |2 |relevance in FL not firmly established[@russler-germainMutationsAssociatedProgression2023]| ## Mutation incidence in large patient cohorts (GAMBL reanalysis) [[include:DLBCL_CD70.md]] [[include:FL_CD70.md]] ## Mutation pattern and selective pressure estimates [[include:dnds_CD70.md]] ## CD70 Hotspots | Chromosome |Coordinate (hg19) | ref>alt | HGVSp | | :---:| :---: | :--: | :---: | | chr19 | 6590145 | C>T | W55* | | chr19 | 6590138 | C>T | A58T | | chr19 | 6590138 | C>G | A58P | | chr19 | 6590137 | G>A | A58V | | chr19 | 6590116 | G>A | T65I | [[include:browser_CD70.md]] ## Expression ![](images/gene_expression/CD70_by_pathology.svg) [[include:mermaid_CD70.md]] ## References